ECRM Health Care 2009

Three Food and Drug Administration advisory committees voted on sweeping changes regarding the marketing, merchandising and formulation of acetaminophen products last month, though the proposed changes fell short of pulling combination products containing acetaminophen off the market. This ECRM section covers intricacies of the FDA committees' decision, as well as external analgesics, foot care, PSE regulations and baby care. Click below to download the PDF of "ECRM Health Care."